Evaluation of an Algorithm to Guide Patients with Type I Diabetes Treated with Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels.

St Vincents Hospital Melbourne0 个研究点目标入组 60 人开始时间: 2007年4月11日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Type I diabetes (c-peptide negative)- English speaking. Established on pump therapy for at least 3 months and be proficient in the use of an insulin dose calculator. -Proficient at and committed to at least four fingerprick glucose measurements per day.-Willing to use MiniMed MMT 722 glucose sensor >70% of study time period.-Current HbA1c of <9.5% -All should have access to electronic communication ie email.

•Visual Impairment such that the patient is unable to see the screen or fill the reservoir of the CSII device, or read a glucometer display or administer insulin safely using a pen device.- Intellectual or language difficulties such that operation of a CGM or CSII device is precluded.-Significant renal impairment (eGFR <60 mL/min/1.73 m2 )-Eating Disorders.-Major Psychiatric Disorders.-Life threatening illness (eg myocardial infarct) within last three months.- Steroid therapy or the presence of disease states likely to require future steroid therapy.-Abnormal thyroid function.-A history of gastroparesis or delayed gastric emptying.-Untreated/ inadequately treated coeliac disease.-Pregnancy. For women of childbearing age appropriate contraceptive measures should be taken.- A documented history of insulin allergy/ antibodies.-Patients with haemoglobinopathies or patients requiring regular transfusions.

发起方

St Vincents Hospital Melbourne